Anti-Cancer Agents in Medicinal Chemistry
Formerly: Current Medicinal Chemistry - Anti-Cancer Agents
Volume 21, 18 Issues, 2021
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)
This journal supports open access
Open Access Articles
Film-Forming Nanogels: Effects of Nanocarriers and Film-Forming Gel on the Sustained Release of Curcumin
, 2021; 21(5): 658 - 666Khanh T. Nguyen, Phuong H.L. Tran, Hai V. Ngo and Thao T.D. Tran*
Possible Enhancement of Photodynamic Therapy (PDT) Colorectal Cancer Treatment when Combined with Cannabidiol
, 2021; 21(2): 137 - 148Nkune W. Nkune, Cherie A. Kruger* and Heidi Abrahamse
The Killing of Human Neuroblastoma Cells by the Small Molecule JQ1 Occurs in a p53-Dependent Manner
, 2020; 20(13): 1613 - 1625Joseph Mazar*, Caleb Gordon, Varun Naga and Tamarah J. Westmoreland
Proteomic Level Changes on Treatment in MCF-7/DDP Breast Cancer Drug- Resistant Cells
, 2020; 20(6): 687 - 699Gongshen Jin*, Kangwei Wang, Yonghong Liu, Xianhu Liu, Xiaojing Zhang and Hao Zhang
Deglucohellebrin: A Potent Agent for Glioblastoma Treatment
, 2020; 20(1): 103 - 110Evrysthenis Vartholomatos, George A. Alexiou*, Georgios S. Markopoulos, Diamanto Lazari, Olga Tsiftsoglou, Ieremias Chousidis, Ioannis Leonardos and Athanasios P. Kyritsis
Triphenylethylene-Coumarin Hybrid TCH-5c Suppresses Tumorigenic Progression in Breast Cancer Mainly Through the Inhibition of Angiogenesis
, 2019; 19(10): 1253 - 1261Naipeng Cui, Dan-Dan Lin, Yang Shen, Jian-Guo Shi, Bing Wang, Ming-Zhi Zhao, Lishuang Zheng, Hua Chen* and Jian-Hong Shi*
Nicotinamide Overcomes Doxorubicin Resistance of Breast Cancer Cells through Deregulating SIRT1/Akt Pathway
, 2019; 19(5): 687 - 696Yingze Wei, Yan Guo, Jianyun Zhou, Kui Dai, Qiang Xu and Xiaoxia Jin*
New Strategies for Therapeutic Cancer Vaccines
, 2019; 19(2): 213 - 221Hanjiao Qin, Jiyao Sheng, Dan Zhang, Xuewen Zhang, Linlin Liu*, Bingjin Li*, Guangquan Li* and Zhuo Zhang
Trichinella spiralis and Tumors: Cause, Coincidence or Treatment?
, 2018; 18(8): 1091 - 1099Chengshui Liao*, Xiangchao Cheng, Mingyuan Liu*, Xuelin Wang and Pascal Boireau
Astragalin Attenuates UVB Radiation-induced Actinic Keratosis Formation
, 2018; 18(7): 1001 - 1008Na Li, Kun Zhang, Xin Mu, Qiong Tian, Wenli Liu, Tianyuan Gao, Xiaona Ma* and Jian Zhang*
Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals
, 2016; 16(11): 1385 - 1402Alessandra Bosutti, Fabrizio Zanconati, Gabriele Grassi, Barbara Dapas, Sabina Passamonti and Bruna Scaggiante
Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases
, 2016; 16(7): 810 - 815Anna Lisa Iorio, Martina da Ros, Ornella Fantappiè, Maurizio Lucchesi, Ludovica Facchini, Alessia Stival, Sabrina Becciani, Milena Guidi, Claudio Favre, Maurizio de Martino, Lorenzo Genitori and Iacopo Sardi
The Use of Anthracyclines for Therapy of CNS Tumors
, 2015; 15(6): 721 - 727Martina da Ros, Anna Lisa Iorio, Maurizio Lucchesi, Alessia Stival, Maurizio de Martino and Iacopo Sardi
Synthesis, Preferentially Hypoxic Apoptosis and Anti-Angiogenic Activity of 3- Amino-1,2,4-Benzotriazine-1,4-Dioxide Bearing Alkyl Linkers with a 3-Amino-1,2,4- Benzotriazine-1-Oxide Moiety
, 2014; 14(10): 1428 - 1446Chun-I Lee, Chien-Ming Huang, Wen-Hsin Huang and An-Rong Lee
Episensitization: Therapeutic Tumor Resensitization by Epigenetic Agents: A Review and Reassessment
, 2014; 14(8): 1121 - 1127Bryan Oronsky, Neil Oronsky, Susan Knox, Gary Fanger and Jan Scicinski
Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines
, 2014; 14(6): 840 - 851Georgina A. Cardama, Maria J. Comin, Leandro Hornos, Nazareno Gonzalez, Lucas Defelipe, Adrian G. Turjanski, Daniel F. Alonso, Daniel E. Gomez and Pablo Lorenzano Menna
β2-Microglobulin-mediated Signaling as a Target for Cancer Therapy
, 2014; 14(3): 343 - 352Takeo Nomura, Wen-Chin Huang, Haiyen E. Zhau, Sajni Josson, Hiromitsu Mimata and Leland W. K. Chung
The Immunomodulation and Anti-Inflammatory Effects of Garlic Organosulfur Compounds in Cancer Chemoprevention
, 2014; 14(2): 233 - 240Georgia Schäfer and Catherine H. Kaschula
Cytotoxicity and Apoptosis Induced by a Plumbagin Derivative in Estrogen Positive MCF-7 Breast Cancer Cells
, 2014; 14(1): 170 - 180Sunil Sagar, Luke Esau, Basem Moosa, Niveen M. Khashab, Vladimir B. Bajic and Mandeep Kaur
Differential Effects of Polyphenols on Proliferation and Apoptosis in Human Myeloid and Lymphoid Leukemia Cell Lines
, 2013; 13(10): 1601 - 1613Amani A Mahbub, Christine L. Le Maitre, Sarah L. Haywood-Small, Gordon J. McDougall, Neil A. Cross and Nicola Jordan-Mahy
The Use of Lentinan for Treating Gastric Cancer
, 2013; 13(5): 681 - 688Kenji Ina, Takae Kataoka and Takafumi Ando
Redox-inactive Analogue of Tocotrienol as a Potential Anti-cancer Agent
, 2013; 13(3): 496 - 501Tomohiro Yano, Ayami Sato, Miki Sekine, Nantiga Virgona and Masako Ota
Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
, 2010; 10(10): 753 - 768Carlos Mas-Moruno, Florian Rechenmacher and Horst Kessler
Pharmacogenomics of Human ABC Transporter ABCC11 (MRP8): Potential Risk of Breast Cancer and Chemotherapy Failure
, 2010; 10(8): 617 - 624Yu Toyoda and Toshihisa Ishikawa
New Medical Strategies for Midgut Carcinoids
, 2010; 10(3): 250 - 269Ola Nilsson, Yvonne Arvidsson, Viktor Johanson, Eva Forssell-Aronsson and Hakan Ahlman
Regulation of the Endoplasmic Reticulum Ca2+-Store in Cancer
, 2008; 8(7): 705 - 709A. Bergner and R. M. Huber
The Protein Kinase Inhibitor Balanol: Structure – Activity Relationships and Structure-Based Computational Studies
, 2008; 8(6): 638 - 645Vineet Pande, Maria J. Ramos and Federico Gago
Role of Mismatch Repair and MGMT in Response to Anticancer Therapies
, 2008; 8(4): 368 - 380Ida Casorelli, Maria Teresa Russo and Margherita Bignami
Inhibition of Protein Kinase c-Src as a Therapeutic Approach for Cancer and Bone Metastases
, 2008; 8(3): 342 - 349Nadia Rucci, Maria Susa and Anna Teti
Editor-in-Chief
Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara
Chieti
(Italy)
Biography
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara
Chieti
Biography
Biography of Simone Carradori
Dr. Simone Carradori, after completing graduation in “Drug Chemistry and Technology”, obtained
his PhD in “Pharmaceutical Sciences” at the University of Rome "La Sapienza" (Italy). He
collaborates with several departments abroad. Currently, he is assistant professor at the Department
of Pharmacy of “G. d’Annunzio” University of Chieti-Pescara (Italy). The scientific activity is
mainly focused on the synthesis and characterization of heterocyclic derivatives as well as
extraction of natural compounds with potential biological activity, and is documented from several
papers in international peer-reviewed journals, one European patent and participations in numerous
conferences.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Medicinal Chemistry - Anti-Cancer Agents was launched in 2001 and later renamed in 2006 as Anti-Cancer Agents in Medicinal Chemistry.
Highlighted Articles
Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells, 2014: 14(10); 1315 - 1323
View Abstract Rights and Permissions
Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells, 2014: 14(10); 1315 - 1323
Tania Bour, Xianwen Yang, Weihong Li, Francois Bernardin, Tony Kaoma, Arnaud Muller, Laurent Vallar and Andre Steinmetz.
View Abstract Rights and Permissions
Advertisement
Webmaster Contact: info@benthamscience.net